Serum creatinine to cystatin C ratio in relation to heart failure with preserved ejection fraction

Abstract Background Sarcopenia was recognized to be one of the common comorbidities in heart failure (HF). The sarcopenia index (SI), based on serum creatinine to cystatin C ratio, was developed as a simple tool to evaluate skeletal muscle mass but has not been well-studied in the correlation of lef...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruting Wang, Kai Huang, Hangfeng Ying, Jiahao Duan, Qinwen Feng, Xinying Zhang, Zifeng Wu, Riyue Jiang, Bin Zhu, Ling Yang, Chun Yang
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-024-04359-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850244227282239488
author Ruting Wang
Kai Huang
Hangfeng Ying
Jiahao Duan
Qinwen Feng
Xinying Zhang
Zifeng Wu
Riyue Jiang
Bin Zhu
Ling Yang
Chun Yang
author_facet Ruting Wang
Kai Huang
Hangfeng Ying
Jiahao Duan
Qinwen Feng
Xinying Zhang
Zifeng Wu
Riyue Jiang
Bin Zhu
Ling Yang
Chun Yang
author_sort Ruting Wang
collection DOAJ
description Abstract Background Sarcopenia was recognized to be one of the common comorbidities in heart failure (HF). The sarcopenia index (SI), based on serum creatinine to cystatin C ratio, was developed as a simple tool to evaluate skeletal muscle mass but has not been well-studied in the correlation of left ventricular ejection fraction (LVEF). The aim of this study is to analyze the SI in patients with HF, especially patients with HF with preserved ejection fraction (HFpEF), and to develop a prediction model for HFpEF. Methods The training cohort included 229 hospitalized patients with HF and 73 healthy controls (HCs) from the Third Affiliated Hospital of Soochow University between December 2019 and February 2022. An additional 78 patients with HF hospitalized at the same hospital between March 2022 to June 2023 were considered as an external validation cohort. Binary logistic regression model was used to analyze the influence factors of HFpEF. A prediction model was constructed and optimized based on the least absolute shrinkage and selection operator (LASSO), displayed by Nomogram and verified internally by Bootstrap with 500 resamples. Results SI was significantly different between the HF and HC groups (67.95 ± 13.07 vs. 98.57 ± 31.51) and had a significant negative correlation with LVEF. Multivariate logistic regression demonstrated that SI (OR 0.948, 95% CI 0.914—0.983, P = 0.004) was independently associated with HFpEF. The area under the curve (AUC) for the nomogram constructed based on SI was 0.902. The calibration curve was approximately distributed along the reference line in Bootstrap and the decision curve analysis demonstrated significantly better net benefit in the model. The external validation proved the good predictive performance of the model. Conclusions Lower SI is an independent factor associated with hospitalized patients with HF, especially patients with HFpEF. A prediction nomogram based on SI has good predictive power for HFpEF. Trial registration The study was registered with the China Clinical Trials Centre Registry (registration number: ChiCTR2200063401).
format Article
id doaj-art-754afec6d4e94fe2aeebf3a65f87956e
institution OA Journals
issn 1471-2261
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj-art-754afec6d4e94fe2aeebf3a65f87956e2025-08-20T01:59:48ZengBMCBMC Cardiovascular Disorders1471-22612024-12-0124111010.1186/s12872-024-04359-zSerum creatinine to cystatin C ratio in relation to heart failure with preserved ejection fractionRuting Wang0Kai Huang1Hangfeng Ying2Jiahao Duan3Qinwen Feng4Xinying Zhang5Zifeng Wu6Riyue Jiang7Bin Zhu8Ling Yang9Chun Yang10Department of Cardiology, The Third Affiliated Hospital of Soochow UniversityDepartment of Cardiology, The Third Affiliated Hospital of Soochow UniversityDepartment of Cardiology, The Third Affiliated Hospital of Soochow UniversityDepartment of Cardiology, The Third Affiliated Hospital of Soochow UniversityDepartment of Cardiology, The Third Affiliated Hospital of Soochow UniversityDepartment of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical UniversityDepartment of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical UniversityDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical UniversityDepartment of Critical Care Medicine, The Third Affiliated Hospital of Soochow UniversityDepartment of Cardiology, The Third Affiliated Hospital of Soochow UniversityDepartment of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical UniversityAbstract Background Sarcopenia was recognized to be one of the common comorbidities in heart failure (HF). The sarcopenia index (SI), based on serum creatinine to cystatin C ratio, was developed as a simple tool to evaluate skeletal muscle mass but has not been well-studied in the correlation of left ventricular ejection fraction (LVEF). The aim of this study is to analyze the SI in patients with HF, especially patients with HF with preserved ejection fraction (HFpEF), and to develop a prediction model for HFpEF. Methods The training cohort included 229 hospitalized patients with HF and 73 healthy controls (HCs) from the Third Affiliated Hospital of Soochow University between December 2019 and February 2022. An additional 78 patients with HF hospitalized at the same hospital between March 2022 to June 2023 were considered as an external validation cohort. Binary logistic regression model was used to analyze the influence factors of HFpEF. A prediction model was constructed and optimized based on the least absolute shrinkage and selection operator (LASSO), displayed by Nomogram and verified internally by Bootstrap with 500 resamples. Results SI was significantly different between the HF and HC groups (67.95 ± 13.07 vs. 98.57 ± 31.51) and had a significant negative correlation with LVEF. Multivariate logistic regression demonstrated that SI (OR 0.948, 95% CI 0.914—0.983, P = 0.004) was independently associated with HFpEF. The area under the curve (AUC) for the nomogram constructed based on SI was 0.902. The calibration curve was approximately distributed along the reference line in Bootstrap and the decision curve analysis demonstrated significantly better net benefit in the model. The external validation proved the good predictive performance of the model. Conclusions Lower SI is an independent factor associated with hospitalized patients with HF, especially patients with HFpEF. A prediction nomogram based on SI has good predictive power for HFpEF. Trial registration The study was registered with the China Clinical Trials Centre Registry (registration number: ChiCTR2200063401).https://doi.org/10.1186/s12872-024-04359-zHeart failurePreserved ejection fractionSarcopenia indexPrediction model
spellingShingle Ruting Wang
Kai Huang
Hangfeng Ying
Jiahao Duan
Qinwen Feng
Xinying Zhang
Zifeng Wu
Riyue Jiang
Bin Zhu
Ling Yang
Chun Yang
Serum creatinine to cystatin C ratio in relation to heart failure with preserved ejection fraction
BMC Cardiovascular Disorders
Heart failure
Preserved ejection fraction
Sarcopenia index
Prediction model
title Serum creatinine to cystatin C ratio in relation to heart failure with preserved ejection fraction
title_full Serum creatinine to cystatin C ratio in relation to heart failure with preserved ejection fraction
title_fullStr Serum creatinine to cystatin C ratio in relation to heart failure with preserved ejection fraction
title_full_unstemmed Serum creatinine to cystatin C ratio in relation to heart failure with preserved ejection fraction
title_short Serum creatinine to cystatin C ratio in relation to heart failure with preserved ejection fraction
title_sort serum creatinine to cystatin c ratio in relation to heart failure with preserved ejection fraction
topic Heart failure
Preserved ejection fraction
Sarcopenia index
Prediction model
url https://doi.org/10.1186/s12872-024-04359-z
work_keys_str_mv AT rutingwang serumcreatininetocystatincratioinrelationtoheartfailurewithpreservedejectionfraction
AT kaihuang serumcreatininetocystatincratioinrelationtoheartfailurewithpreservedejectionfraction
AT hangfengying serumcreatininetocystatincratioinrelationtoheartfailurewithpreservedejectionfraction
AT jiahaoduan serumcreatininetocystatincratioinrelationtoheartfailurewithpreservedejectionfraction
AT qinwenfeng serumcreatininetocystatincratioinrelationtoheartfailurewithpreservedejectionfraction
AT xinyingzhang serumcreatininetocystatincratioinrelationtoheartfailurewithpreservedejectionfraction
AT zifengwu serumcreatininetocystatincratioinrelationtoheartfailurewithpreservedejectionfraction
AT riyuejiang serumcreatininetocystatincratioinrelationtoheartfailurewithpreservedejectionfraction
AT binzhu serumcreatininetocystatincratioinrelationtoheartfailurewithpreservedejectionfraction
AT lingyang serumcreatininetocystatincratioinrelationtoheartfailurewithpreservedejectionfraction
AT chunyang serumcreatininetocystatincratioinrelationtoheartfailurewithpreservedejectionfraction